The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Prognostic factors in cancer
Abstract
Diagnosis, prognosis, and treatment are the three core elements of the art of medicine. Modern medicine pays more attention to diagnosis and treatment but prognosis has been a part of the practice of medicine much longer than diagnosis. Cancer is a heterogeneous group of disease characterized by growth, invasion and metastasis. To plan the management of an individual cancer patient, the fundamental knowledge base includes the site of origin of the cancer, its morphologic type, and the prognostic factors specific to that particular patient and cancer. Most prognostic factors literature describes those factors that directly relate to the tumor itself. However, many other factors, not directly related to the tumor, also affect the outcome. To comprehensively represent these factors we propose three broad groupings of prognostic factors: ‘tumor’‐related prognostic factors, ‘host’‐related prognostic factors, and ‘environment’‐related prognostic factors. Some prognostic factors are essential to decisions about the goals and choice treatment, while others are less relevant for these purposes. To guide the use of various prognostic factors we have proposed a grouping of factors based on their relevance in everyday practice; these comprise ‘essential,’ ‘additional,’ and ‘new and promising factors.’ The availability of a comprehensive classification of prognostic factors assures an ordered and deliberate approach to the subject and provide safeguard against skewed approaches that may ignore large parts of the field. The current attention to tumor factors has diminished the importance of ‘patient’ (i.e., ‘host’), and almost completely overshadows the importance of the ‘environment’. This ignores the fact that the latter presents the greatest potential for immediate impact. The acceptance of a generic prognostic factor classification would facilitate communication and education about this most important subject in oncology. Semin. Surg. Oncol. 21:13–18, 2003. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,330
AJCC Cancer Staging Manual. 6th ed
Greene, F., Page, D., Id, F., Fritz, J., Balch, C., & Haller, D. (2002) · Cited by 2,324
Gascoyne, R. D., Adomat, S. A., Krajewski, S., Krajewska, M., Horsman, D. E., Tolcher, A. W., O'Reilly, S. E., Hoskins, P., Coldman, A. J., Reed, J. C., et al. (1997) · Blood · doi:10.1182/blood.v90.1.244 · Cited by 509
Goldenberg, M. M. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88288-0 · Cited by 453
Singer, S., Rubin, B. P., Lux, M. L., Chen, C.-J., Demetri, G. D., Fletcher, C. D. �., & Fletcher, J. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.095 · Cited by 420
Patient age, histologic features, and length of survival in patients with glioblastoma multiforme
Burger, P. C., & Green, S. B. (1987) · Cancer · doi:10.1002/1097-0142(19870501)59:9<1617::aid-cncr2820590916>3.0.co;2-x · Cited by 391
Tsang, R. W., Brierley, J. D., Simpson, W. J., Panzarella, T., Gospodarowicz, M. K., & Sutcliffe, S. B. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2<389::aid-cncr19>3.0.co;2-v · Cited by 381
Self-citationGillis, C. R., & Hole, D. J. (1996) · BMJ · doi:10.1136/bmj.312.7024.145 · Cited by 311
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor
Stauder, R., Eisterer, W., Thaler, J., & Gunthert, U. (1995) · Blood · doi:10.1182/blood.v85.10.2885.bloodjournal85102885 · Cited by 221
Compton, C. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-384a-pfic · Cited by 185
NEUMANN, H. P. H., BENDER, B. U., BERGER, D. P., LAUBENBERGER, J., SCHULTZE-SEEMANN, W., WETTERAUER, U., FERSTL, F. J., HERBST, E. W., SCHWARZKOPF, G., HES, F. J., et al. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62509-6 · Cited by 183
p53 Status and Prognosis of Locally Advanced Prostatic Adenocarcinoma: a Study Based on RTOG 8610
Grignon, D. J., Sarkar, F. H., Forman, J. D., Caplan, R., Pajak, T. F., Lawton, C. A., Hammond, E. H., Pilepich, M. V., Mesic, J., Fu, K. K., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.2.158 · Cited by 176
Depressive reactions to lung cancer are common and often followed by a poor outcome.
Buccheri, G. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11010173 · Cited by 122
Does a centralized radiotherapy system provide adequate access to care?
Mackillop, W. J., Groome, P. A., Zhang-Solomons, J., Zhou, Y., Feldman‐Stewart, D., Paszat, L. F., Dixon, P., Holowaty, E. J., & Cummings, B. J. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1261 · Cited by 119
The ellipsis of prognosis in modern medical thought
Christakis, N. A. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00100-1 · Cited by 91
Clinical status and optimal use of rituximab for B-cell lymphomas.
McLaughlin, P. J., White, C. A., Grillo-López, A. J., & Maloney, D. G. (1998) · PubMed · Cited by 84
The Importance of Prognosis in Cancer Medicine
Mackillop, W. J. (2006) · Wiley eBooks · doi:10.1002/0471463736.tnmp01.pub2 · Cited by 34
Medical prognosis ? Some fundamentals
Rizzi, D. A. (1993) · Metamedicine · doi:10.1007/bf00996342 · Cited by 33
Cited by
Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging
O'Connell, J. B., Maggard, M. A., & Ko, C. Y. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh275 · Cited by 1,599
Genetic Pathways to Glioblastoma
Ohgaki, H., Dessen, P., Jourde, B., Horstmann, S., Nishikawa, T., Di Patre, P.-L., Burkhard, C., Schüler, D., Probst-Hensch, N. M., Maiorka, P. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1337 · Cited by 1,270
Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
Riley, R. D., Hayden, J. A., Steyerberg, E. W., Moons, K. G. M., Abrams, K., Kyzas, P. A., Malats, N., Briggs, A., Schroter, S., Altman, D. G., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001380 · Cited by 823
Cupp, M. A., Cariolou, M., Tzoulaki, I., Aune, D., Evangelou, E., & Berlanga-Taylor, A. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01817-1 · Cited by 697
Goldstraw, P., Ball, D., Jett, J. R., Le Chevalier, T., Lim, E., Nicholson, A. G., & Shepherd, F. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62101-0 · Cited by 711
Metadata
- Authors
- Gospodarowicz, M., & O'Sullivan, B.
- Venue
- Seminars in Surgical Oncology
- Publisher
- Wiley
- Published
- 2003-01
- Volume
- 21
- Issue
- 1
- Pages
- 13-18
- ISSN
- 1098-2388 (ISSN-L)
- 8756-0437
- OpenAlex
- W2036489555
- Cited by
- 283
- References
- 20
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.